On June 28, 2020, the Board of Directors (the 'Board') of Clinigence Holdings, Inc. (the 'Company') accepted the resignation of Mark Fawcett from the Board and related responsibilities on Chairman of the Compensation Committee. Mr. Fawcett's resignation is not the result of any disagreement with the Company on any matter relating to the Company's operations, policies or practices. Effective upon Mr. Fawcett's resignation as a director, the Company's Board will be reduced from eight to seven directors.